با برنامه Player FM !
02_04 Recurrence risk scores and CDK inhibitors for Early Breast Cancer
Manage episode 347473110 series 3335024
1. Recurrence Risk Scores
2. TailorRx, RxPonder, MINDACT Trials Overview
3. Introduction to CDK 4/6 inhibitors
4. PALLAS and MONARCH-E Discussion
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references recommended to read related to this specific episode:
1. Johnston SRD et al. JCO. 2020;38(34):3987-3998. doi:10.1200/JCO.20.02514
2. Harbeck N et al. Ann Oncol. 2021;32(12):1571-1581. doi:10.1016/J.ANNONC.2021.09.015
3. Mayer EL et al. Lancet Oncol. 2021;22(2):212-222. doi:10.1016/S1470-2045(20)30642-2
4. Cardoso F et al. NEJM. 2016;375(8):717-729. doi:10.1056/NEJMOA1602253
5. Kalinsky K et al. NEJM. 2021;385(25):2336-2347. doi:10.1056/NEJMOA2108873/
6. Sparano JA et al. NEJM. 2019;380(25):2395-2405. doi:10.1056/NEJMOA1904819/
7. Paik S et al. JCO. 2006;24(23):3726-3734. doi:10.1200/JCO.2005.04.7985
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
Tags
Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
48 قسمت
02_04 Recurrence risk scores and CDK inhibitors for Early Breast Cancer
Talking About Tumors with Ryann and Ryan - A medical oncology podcast
Manage episode 347473110 series 3335024
1. Recurrence Risk Scores
2. TailorRx, RxPonder, MINDACT Trials Overview
3. Introduction to CDK 4/6 inhibitors
4. PALLAS and MONARCH-E Discussion
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references recommended to read related to this specific episode:
1. Johnston SRD et al. JCO. 2020;38(34):3987-3998. doi:10.1200/JCO.20.02514
2. Harbeck N et al. Ann Oncol. 2021;32(12):1571-1581. doi:10.1016/J.ANNONC.2021.09.015
3. Mayer EL et al. Lancet Oncol. 2021;22(2):212-222. doi:10.1016/S1470-2045(20)30642-2
4. Cardoso F et al. NEJM. 2016;375(8):717-729. doi:10.1056/NEJMOA1602253
5. Kalinsky K et al. NEJM. 2021;385(25):2336-2347. doi:10.1056/NEJMOA2108873/
6. Sparano JA et al. NEJM. 2019;380(25):2395-2405. doi:10.1056/NEJMOA1904819/
7. Paik S et al. JCO. 2006;24(23):3726-3734. doi:10.1200/JCO.2005.04.7985
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
Tags
Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
48 قسمت
همه قسمت ها
×به Player FM خوش آمدید!
Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.